Tributary Capital Management, LLC - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Tributary Capital Management, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2014$3,180,000
-1.5%
382,7310.0%0.67%
+4.4%
Q4 2013$3,230,000
+8.7%
382,731
+2.6%
0.64%
+4.2%
Q3 2013$2,972,000
+35.2%
372,954
+31.0%
0.61%
+70.6%
Q2 2013$2,199,000–284,784–0.36%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2013
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders